Login to Your Account



Merck Dumps Oral Vernakalant; Cardiome Shares in Free Fall

By Catherine Shaffer
Staff Writer

Tuesday, March 20, 2012
An abrupt termination by Merck & Co. Inc. of development of oral vernakalant caught Cardiome Pharma Corp., of Vancouver, British Columbia, flatfooted as it prepared to release a financial update Monday.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription